As ANH General Counsel Jonathan Emord explains, "The overwhelming majority of manufacturers and distributors that have lawfully and safely sold their products for decades ought not be treated like criminals and shackled by a paternalistic FDA nanny state." Read our take on what this proposed rule could mean, why it matters, and what comes next: #HealthFreedom #FoodSafety #Transparency #NaturalHealth To view or add a comment, sign in 3,842 followers More from this author Interpretation of New Zealand's Draft Import Health Standard for Animal Products Intended for Human Use Global Foodmate Consulting 3d Weekly Review of Food Standards & Regulations (July 13- July 19, 2026) Global Foodmate Consulting 4d 706 Batches of Imported Food Denied Entry
Patients with diabetic retinopathy require careful monitoring, particularly if rapid glycaemic improvement occurs, as this has been associated with temporary worsening of retinopathy with other diabetes medications
References: Gibson GR et al., Gut, 2017 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation
Individuals were included in the study if they had been diagnosed with type 2 diabetes and tobacco use disorder but had not used any medications for diabetes in the past year and had one or more diseases such as hypertension, hyperlipidemia, obesity, hypercholesterolemia, stroke, or heart disease